The development of CD4 binding site antibodies during HIV-1 infection.

Journal of Virology
Rebecca LynchJohn R Mascola

Abstract

Broadly neutralizing antibodies to the CD4 binding site (CD4bs) of gp120 are generated by some HIV-1-infected individuals, but little is known about the prevalence and evolution of this antibody response during the course of HIV-1 infection. We analyzed the sera of 113 HIV-1 seroconverters from three cohorts for binding to a panel of gp120 core proteins and their corresponding CD4bs knockout mutants. Among sera collected between 99 and 258 weeks post-HIV-1 infection, 88% contained antibodies to the CD4bs and 47% contained antibodies to resurfaced stabilized core (RSC) probes that react preferentially with broadly neutralizing CD4bs antibodies (BNCD4), such as monoclonal antibodies (MAbs) VRC01 and VRC-CH31. Analysis of longitudinal serum samples from a subset of 18 subjects revealed that CD4bs antibodies to gp120 arose within the first 4 to 16 weeks of infection, while the development of RSC-reactive antibodies was more varied, occurring between 10 and 152 weeks post-HIV-1 infection. Despite the presence of these antibodies, serum neutralization mediated by RSC-reactive antibodies was detected in sera from only a few donors infected for more than 3 years. Thus, CD4bs antibodies that bind a VRC01-like epitope are often induced d...Continue Reading

References

Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C F BarbasE Norrby
Aug 28, 2007·Nature Medicine·Yuxing LiJohn R Mascola
Jun 3, 2009·The Journal of Experimental Medicine·Nilu GoonetillekeAndrew J McMichael
Dec 17, 2009·Nature Reviews. Immunology·Andrew J McMichaelBarton F Haynes
Feb 23, 2010·The Journal of Infectious Diseases·Zelda EulerHanneke Schuitemaker
Jan 21, 2011·PLoS Pathogens·Iliyana MikellLeonidas Stamatatos
Aug 19, 2011·Nature·Laura M WalkerPascal Poignard

❮ Previous
Next ❯

Citations

Jul 31, 2013·Planta·Dania O Govea-AlonsoSergio Rosales-Mendoza
Apr 5, 2013·Nature·Hua-Xin LiaoBarton F Haynes
Feb 13, 2013·The Journal of Experimental Medicine·Laura E McCoy, Robin A Weiss
Mar 27, 2013·The Journal of Experimental Medicine·Andrew T McGuireLeonidas Stamatatos
Aug 8, 2012·PloS One·Arie RyvkinJonathan M Gershoni
Mar 13, 2014·The Journal of Clinical Investigation·Mattia BonsignoriBarton F Haynes
Mar 12, 2013·Antioxidants & Redox Signaling·Meghan M Delmastro-GreenwoodJon D Piganelli
Jun 4, 2014·The Journal of Clinical Investigation·Lela KardavaAnthony S Fauci
Aug 26, 2014·Viruses·Nancy StonosNiel Karrow
Nov 14, 2015·Annual Review of Medicine·Saheli SadanandGalit Alter
Jan 31, 2017·Immunological Reviews·Susan Moir, Anthony S Fauci
Jan 31, 2017·Immunological Reviews·Leonidas StamatatosAndrew T McGuire
Jan 31, 2017·Immunological Reviews·George K LewisAnthony L DeVico
Jan 31, 2017·Immunological Reviews·Laura E McCoy, Dennis R Burton
Feb 2, 2017·Annual Review of Immunology·Florian Weisel, Mark Shlomchik
Nov 7, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yajing ChenYuxing Li
Nov 25, 2017·Nature Communications·Wilton B WilliamsLaurent Verkoczy

❮ Previous
Next ❯